Related Experiment Video
Updated: Jan 3, 2026

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Published on: June 20, 2025
Hemostatic abnormalities in adult patients with Marfan syndrome
Katharina T I Kornhuber1, Heide Seidel1,2, Claudia Pujol1
1Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University Munich, Munich, Germany.
Background:
Aortic root ectasia might induce hemostatic disorders in patients with Marfan syndrome (MFS) via altered blood flow and rheology. The aim of this study was to explore the hemostasis in patients with MFS compared with healthy controls.
Methods:
In this cross-sectional case-control study we included patients with verified MFS (n=51) and sex- and age-matched healthy controls (n=50). Main criteria were the aortic root in echocardiography and cardiac magnetic resonance imaging (MRI), and the coagulation status.
Results:
When compared with healthy controls, patients with MFS showed significantly increased diameters of the aortic roots (43.0±7.72 vs. 28.8±3.74 mm, P<0.001) and aortic Z-scores (4.36±2.77 vs. 0.948±1.09, P<0.001), considerably higher values of Multiplate® tests (e.g., MP-ADP: 878.4±201.7 vs. 660.4±243.6 AU*min, P<0.001) and PFA-100® tests (PFA Col/ADP: 102.5±45.5 vs. 91.1±46.2 s, P<0.05), PTT (30.0±3.91 vs. 28.7±2.50 s, P<0.05) and D-dimers (0.488±0.665 vs. 0.254±0.099 mg/L, P<0.001). In MFS von Willebrand factor (VWF) activity (81.9%±41.8% vs. 106.3%±41.5%, P<0.05) and antigen (93.8%±43.9% vs. 118.8%±47.8%, P<0.05) and factor VIII activity (108.9%±29.6% vs. 126.7%±28.4%, P<0.05) were reduced. Significant positive correlations were found between aortic diameters and D-dimers (all P<0.05), as well as PFA Col/ADP (all P<0.01) in MFS patients. Factor VIII activity correlated significantly negatively with the diameter of the aortic root in MFS (r=-0.55, P<0.05).
Conclusions:
In conclusion, our study reveals hemostatic deviations in patients with MFS. Further studies are necessary to understand the causal relationship and the exact pathomechanism.
Insights
Patients with Marfan syndrome (MFS) exhibit significant hemostatic deviations, including altered platelet function and increased D-dimers, linked to aortic root ectasia. These findings highlight potential bleeding risks in MFS patients.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Genetics
Background:
- Marfan syndrome (MFS) is associated with aortic root ectasia, potentially impacting hemostasis due to altered blood flow.
- Understanding hemostatic changes in MFS is crucial for managing associated cardiovascular risks.
Purpose of the Study:
- To investigate and compare hemostasis in patients with Marfan syndrome (MFS) against healthy controls.
- To explore the relationship between aortic root dimensions and coagulation status in MFS.
Main Methods:
- A cross-sectional case-control study included 51 MFS patients and 50 healthy controls.
- Aortic root dimensions were assessed using echocardiography and cardiac MRI.
- Coagulation status was evaluated using Multiplate®, PFA-100®, PTT, D-dimers, von Willebrand factor (VWF) activity/antigen, and factor VIII activity.
Main Results:
- MFS patients displayed significantly larger aortic root diameters and Z-scores compared to controls.
- Elevated Multiplate® (MP-ADP) and PFA-100® (PFA Col/ADP) test values, along with increased D-dimers, were observed in MFS patients.
- Reduced VWF activity/antigen and factor VIII activity were noted in MFS patients, with significant correlations between aortic diameter and D-dimers/PFA Col/ADP, and an inverse correlation with factor VIII activity.
Conclusions:
- The study confirms significant hemostatic deviations in patients with Marfan syndrome.
- Aortic root ectasia in MFS is associated with distinct alterations in platelet function, coagulation, and fibrinolysis.
- Further research is warranted to elucidate the precise pathomechanisms and causal relationships involved.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Aneurysm I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Mitral Valve Prolapse I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection

